此外，本论文中还进行了抗血栓药物普拉格雷的合成研究工作。
Moreover, we studied and carried out the synthesis of anti-blood drug Prasugrel.
目的调查缺血性脑卒中患者二级预防中抗血栓药物的使用情况，并分析其影响因素。
ObjectiveTo investigate the utilization status of antithrombotic drugs in ischemic stroke survivors for secondary prevention and to identify factors influencing such treatment.
综述了近年来抗血栓药物中生化药物的作用机制，临床应用以及优缺点，为寻找安全、有效的新抗栓药物提供参考。
In this paper, the antithrombotic action and clinical application of biochemical drugs were introduced, the advantages and disadvantages of different biochemical drugs were also reviewed.
DebabrataDash和他的同事们指出现在急需一种新型的抗血栓制剂，因为传统药物经常引起危险的出血情况。
Debabrata Dash and colleagues point out that patients urgently need new anti-thrombotic agents because traditionally prescribed medications too-often cause dangerous bleeding.
我们有很好的药物，而且抗血栓治疗药物还在不断改进。
We have very good drugs and the anti-thrombotic drug therapy is still improving.
脂质体作为溶栓药物载体，经RGDS修饰后，具有较好的靶向性抗血栓作用。
The results show liposomes as the carrier of medicine has better target anti-thrombus effect after RGDS modifies it.
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
本发明涉及治疗心脑血管疾病的药物，具体地说是溴酚类化合物在制备治疗抗血栓形成作用药物中的应用。
The invention relates to a drug for treating cardiovascular and cerebrovascular diseases, particularly to an application of bromophenols in preparing drugs for treating thrombosis.
摘要：阿司匹林是抗血栓治疗的重要药物，阿司匹林抵抗是影响其疗效的常见原因。
ABSTRACT: aspirin is an important antithrombotic agent. However, its clinical benefit is impaired by aspirin resistance.
摘要：阿司匹林是抗血栓治疗的重要药物，阿司匹林抵抗是影响其疗效的常见原因。
ABSTRACT: aspirin is an important antithrombotic agent. However, its clinical benefit is impaired by aspirin resistance.
应用推荐